Skip to main content
Grifols, S.A. (GRFS)
NASDAQ: GRFS · Real-Time Price · USD
8.75
+0.15 (1.80%)
At close: Mar 9, 2026, 4:00 PM EDT
8.76
+0.02 (0.17%)
After-hours: Mar 9, 2026, 4:01 PM EDT

Grifols Revenue

In the year 2025, Grifols had annual revenue of 7.52B EUR with 4.33% growth. Grifols had revenue of 1.98B in the quarter ending December 31, 2025, with 0.32% growth.

Revenue (ttm)
7.52B EUR
Revenue Growth
+4.33%
P/S Ratio
0.81
Revenue / Employee
316,974 EUR
Employees
23,737
Market Cap
7.16B USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20257.52B312.00M4.33%
Dec 31, 20247.21B620.00M9.41%
Dec 31, 20236.59B528.03M8.71%
Jan 1, 20236.06B1.13B22.92%
Dec 31, 20214.93B-406.92M-7.62%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Merck & Co. 65.01B
Pfizer 62.58B
Sanofi 54.85B
Novo Nordisk 48.59B
Bristol-Myers Squibb Company 48.19B
GSK plc 43.97B
Amgen 36.75B
Gilead Sciences 29.44B
Revenue Rankings

GRFS News

More News